Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set Christopher.

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Guillaume Bouguen, Barrett G. Levesque, Brian G

Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab William J. Sandborn, Maria T. Abreu, Geert.

Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case–Control and Cohort Studies Guillaume Pineton de Chambrun, Luc.

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease Laurent Peyrin-Biroulet, Gert.

Volume 135, Issue 4, Pages (October 2008)

Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis Alexander C. Ford, Khurram J. Khan, William.

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to- Moderately Active Ulcerative Colitis Ajit Sood, Vandana Midha, Govind K.

Pichamol Jirapinyo, Christopher C. Thompson

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

A Shocking Cystory Clinical Gastroenterology and Hepatology

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study Harry Wu, Geoffrey C. Nguyen Clinical.

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

Laurent Peyrin-Biroulet, Julián Panés, William J

Prevalence of Dyspepsia in Individuals With Gastroesophageal Reflux–Type Symptoms in the Community: A Systematic Review and Meta-analysis Leonardo H.

Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review Marin J. de Jong,

Rebekah S. Wieland, Richard S. Zubarik, Maryam J. Zenali

Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies Tine Jess, Christine Rungoe, Laurent.

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen, Bruce A

Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic.

Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia Gene K. Ma, Uri Ladabaum Clinical Gastroenterology.

Volume 148, Issue 5, Pages e3 (May 2015)

Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled.

Volume 155, Issue 1, Pages (July 2018)

Bisphosphonates Are Associated With Reduced Risk of Colorectal Cancer: A Systematic Review and Meta-analysis Siddharth Singh, Abha Goyal Singh, Mohammad.

Amie L. Harvey, Tommy Yen, Anand Kunda

Efficacy and Durability of Radiofrequency Ablation for Barrett's Esophagus: Systematic Review and Meta-analysis Eric S. Orman, Nan Li, Nicholas J. Shaheen

Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study William J. Sandborn, William F. Stenson,

Human Papillomavirus–Related Rectal Squamous Cell Carcinoma in a Patient With Ulcerative Colitis Diagnosed on Narrow-Band Imaging Ivana Dzeletovic, Shabana.

Volume 132, Issue 5, Pages (May 2007)

Implementing the Concept of Continuous Clinical Response Into Clinical Practice for Ulcerative Colitis Laurent Peyrin-Biroulet, Gert Van Assche, Alessandro.

New Models of Gastroenterology Practice

William J. Sandborn, Stefan Schreiber, Brian G

Efficient Early Drug Development for Ulcerative Colitis

Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis

Effect of Human Immunodeficiency Virus and Antiretrovirals on Outcomes of Hepatitis C: A Systematic Review From an Epidemiologic Perspective Jennifer.

What Is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Systematic Review and Meta-analysis Alexander C. Ford,

Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases Michael D.

Intragastric Fistula After Multiple Sphere Magnet Ingestion

David H. Bruining, William J. Sandborn

Short-term and Long-term Efficacy of Psychological Therapies for Irritable Bowel Syndrome: A Systematic Review and Meta-analysis Kelsey T. Laird, Emily.

Volume 135, Issue 5, Pages (November 2008)

Peter Bytzer Clinical Gastroenterology and Hepatology

Rebecca M. Lovell, Alexander C. Ford

Neovaginal Sparing in a Transgender Woman With Ulcerative Colitis

Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease A. Pali S. Hungin, Catherine Hill, Michael.

Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis Shailja C.

Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn’s Disease or Ulcerative Colitis: A Systematic.

Issue Highlights Clinical Gastroenterology and Hepatology

Controversies in Ulcerative Colitis: A Survey Comparing Decision Making of Experts Versus Community Gastroenterologists Brennan M.R. Spiegel, Wayne Ho,

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

James Allison, Lisa J. Herrinton, Liyan Liu, Jenny Yu, James Lowder

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease Jennifer Jones, Edward V. Loftus, Remo Panaccione,

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Issue Highlights Clinical Gastroenterology and Hepatology

Coloduodenal Fistula in Crohn’s Disease

Matthew J. Lee, Claire E. Parker, Sarah R

Adverse Outcomes: Why Bad Things Happen to Good People

Medical Therapy for Refractory Pediatric Crohn’s Disease

Issue Highlights Clinical Gastroenterology and Hepatology

The Role of Psychosocial Care in Adapting to Health Care Reform

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Jean-Frédéric Colombel,

Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis Tine Jess, Anthony Lopez, Mikael Andersson,

Presentation transcript:

Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set Christopher Ma, Remo Panaccione, Richard N. Fedorak, Claire E. Parker, Tran M. Nguyen, Reena Khanna, Corey A. Siegel, Laurent Peyrin-Biroulet, Geert D’Haens, William J. Sandborn, Brian G. Feagan, Vipul Jairath Clinical Gastroenterology and Hepatology Volume 16, Issue 5, Pages 637-647.e13 (May 2018) DOI: 10.1016/j.cgh.2017.08.025 Copyright © 2018 AGA Institute Terms and Conditions

Figure 1 Flow diagram for assessment of trials identified by the search strategy. RCT, randomized controlled trial; UCDAI, Ulcerative Colitis Disease Activity Index. Clinical Gastroenterology and Hepatology 2018 16, 637-647.e13DOI: (10.1016/j.cgh.2017.08.025) Copyright © 2018 AGA Institute Terms and Conditions

Figure 2 Proportion of placebo-controlled ulcerative colitis trials reporting key efficacy and safety outcome domains, stratified by decade of publication. Clinical Gastroenterology and Hepatology 2018 16, 637-647.e13DOI: (10.1016/j.cgh.2017.08.025) Copyright © 2018 AGA Institute Terms and Conditions

Figure 3 Outcome reporting matrix for placebo-controlled ulcerative colitis trials. Clinical Gastroenterology and Hepatology 2018 16, 637-647.e13DOI: (10.1016/j.cgh.2017.08.025) Copyright © 2018 AGA Institute Terms and Conditions